It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2008.
2008 | Hyderabad, Telangana, India | ActiveAbode Drugs Private Limited, a active private limited company, was established on 25 April 2008 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the professional, scientific and technical sector, it holds CIN: U24232TG2008PTC058838. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Prakash Rao Nayaneni (Director), Prakash Sharat Kumar Naineni (Director). It holds ₹2.98 M open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at H.No.5-4-22/1, Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, 500072.
U24232TG2008PTC058838
058838
25 April 2008
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Abode Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Rao Nayaneni | Director | 25 Apr 2008 | Current |
| Prakash Sharat Kumar Naineni | Director | 25 Apr 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Abode Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 33.28% decrease. The company also saw a substantial fall in profitability, with a 75.29% decrease in profit. The company's net worth moved up by a moderate rise of 3.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Abode Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,978,599.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Feb 2021 | Hdfc Bank Limited | ₹1.54 M | Open |
| 25 Jan 2021 | Hdfc Bank Limited | ₹1.44 M | Open |
Explore comprehensive loan charge details -
Abode Drugs has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Abode Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abode Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.54 M with Charge ID 100443716 was registered on 16 Feb 2021. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.44 M with Charge ID 100443091 was registered on 25 Jan 2021. was documented.
Abode Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was recorded as a recent event.
Abode Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was recorded as a recent event.
Prakash Rao Nayaneni was appointed as a Director was appointed as a Director on 25 Apr 2008 & has been associated with this company since 17 years 7 months . was recorded as a recent event.
The activity Prakash Sharat Kumar Naineni was appointed as a Director was appointed as a Director on 25 Apr 2008 & has been associated with this company since 17 years 7 months . was completed.
The CIN of Abode Drugs Private Limited is U24232TG2008PTC058838.
Abode Drugs Private Limited is headquartered at H.No.5-4-22/1, Sri Rama Nilayam Kukatpally, Hyderabad, Telangana, 500072.
Abode Drugs Private Limited was incorporated on 25 April 2008.
The current directors of Abode Drugs Private Limited are
The primary industry of Abode Drugs Private Limited is Professional, Scientific And Technical.
Abode Drugs Private Limited is unlisted.
The authorized capital of Abode Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Abode Drugs Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX